A clinical-grade hiPSC, derived from cord blood, was provided by our collaborator Yipcell Inc.
and has been maintained and studied in non-GMP laboratory settings.

Two different protocols were used to generate CECs: the first method involved differentiating iPSCs into CECs via the NCC stage,
while the second method entailed direct differentiation of iPSCs into CECs without the NCC step.